Cns Pharmaceuticals earnings were -$14.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CNSP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.2M, down 43.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNSP reported annual earnings of -$14.9M, with -21.2% growth. The next CNSP earnings date is Apr 30, 2025.
Cns Pharmaceuticals Earnings Reports & History FAQ
What were Cns Pharmaceuticals's earnings last quarter?
On CNSP's earnings call on Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q4 2024 earnings per share (EPS) of $38.13, up 101.6% year over year. Total CNSP earnings for the quarter were -$3.18 million. In the same quarter last year, Cns Pharmaceuticals's earnings per share (EPS) was -$2,385.11.
The next CNSP earnings date is Invalid Date. Add CNSP to your watchlist to be reminded of Cns Pharmaceuticals's next earnings date.
What was CNSP's earnings growth in the past year?
As of Cns Pharmaceuticals's earnings date in Invalid Date, Cns Pharmaceuticals's earnings has grown year over year. CNSP earnings in the past year totalled -$14.86 million.
Is Cns Pharmaceuticals profitable or losing money?
As of the last Cns Pharmaceuticals earnings report, Cns Pharmaceuticals is currently losing money. Cns Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$14.86 million, a 21.18% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.